Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Dionex Corporation (“Dionex” or the “Company”) (NASDAQ:DNEX) related to the Company’s agreement to be acquired by Thermo Fisher Scientific, Inc. (“Thermo Fisher”). The proposed all-cash transaction is valued at approximately $2.1 billion.

Under the terms of the agreement entered into by the parties, Thermo Fisher will commence a tender offer to acquire all of the outstanding shares of Dionex common stock for $118.50 per share in cash. The board of directors of Dionex has unanimously approved the proposed transaction. If the transaction is completed, Dionex will be integrated into Thermo Fisher’s Analytical Technologies Segment. The transaction is expected to be completed in the first quarter of 2011. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the proposed transaction by the Dionex board of directors.

If you are a shareholder of Dionex, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

Dionex Corp. (MM) (NASDAQ:DNEX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Dionex Corp. (MM).
Dionex Corp. (MM) (NASDAQ:DNEX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Dionex Corp. (MM).